期刊文献+

一种靶向性阳离子多肽载体的表达纯化

Expression and Purification of a Targeted Cationic Polypeptide Vector
下载PDF
导出
摘要 目的:原核表达靶向性阳离子多肽(KH)20-EGF,并对其DNA包装能力进行检验。方法:构建pET28a-(KH)20-EGF原核表达载体。进行酶切和测序鉴定。转化BL21(DE3)后,经过IPTG诱导表达和NTA树脂纯化得到粗提蛋白产物,SDS-PAGE和Western blot鉴定后,将蛋白与质粒DNA混合,用于凝胶阻滞实验分析。结果:重组(KH)20-EGF的产量约为300μg/L。SDS-PAGE和Western blot表明该蛋白的凝胶迁移有些滞后;凝胶阻滞试验发现(KH)20-EGF对质粒DNA的迁移有阻滞作用。结论:成功表达非病毒载体(KH)-EGF并确认其DNA包装能力。 Objective: To obtain a targeting cationic polymers (KH)20-EGF and examine its capacity for DNA condensation. Method: Prokaryotic expresssion plasmid pET28a-( KH)20-EGF was constructed and transformed into BL21( DE3 ). The cationic polypeptide was induced by IPTG and purified using a Ni-NTA column. The purified polypeptide was determined by SDS-PAGE and Western blot analysis. The pDNA package ability of the resulted protein was examined by gel retardation assay. Results: The yield of (KH)20-EGF protein was about 300μg/L. The resulted protein was a little larger than expected when examined by SDS-PAGE and Western blot. Gel retardation assays indicated that (KH)20-EGF can retard the pDNA migration. Conclusion: The non-virus vector (KH)20-EGF was expressed successfully and its capability of DNA condensation was confirmed.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2007年第11期57-60,共4页 China Biotechnology
基金 国家"973"计划资助项目(2004CB518802) 国家自然科学基金资助项目(50603012)
关键词 基因治疗 靶向性非病毒载体 阳离子多肽 原核表达纯化 DNA包装 Gene therapy Non-virus vector Cationic polypeptide Prokaryotic expresssion and purification DNA condensation
  • 相关文献

参考文献13

  • 1El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release,2004,94( 1 ) : 1 - 14.
  • 2Wiethoff C M, Middaugh C R. Barriers to nonviral gene delivery.J Pharm Sci,2003,92(2) :203 -217.
  • 3Davis M E. Non-viral gene delivery systems. Curt Opin Biotechnol,2002,13(2 ) : 128 - 113.
  • 4Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev ,2002,54 (5) :715 - 758.
  • 5Uherek C, Wels W. DNA-carrier proteins for targeted gene delivery. Adv Drug Deliv Rev ,2000,44(2-3 ) : 153 - 166.
  • 6Morris M C, Chaloin L, Heitz F, et al. Translocating peptides and proteins and their use for gene delivery. Curt Opin Biotechnol. 2000,11(5) :461 -466.
  • 7Morris M C, Chaloin L, Mery J, et al. A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucleic Acids Res, 1999 ,27 ( 17 ) :3510 - 3517.
  • 8Harefi A, Megeed Z, Ghandehari H, Recombinant polymerprotein fusion: a promising approach towards efficient and targeted gene delivery. J Gene Med ,2006,8: 468 - 476.
  • 9Van Rossenber S M, Van Keulen A C, Drijfhout J W, et al. Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery. Gene Ther,2004,11 ( 5 ) : 457 - 464.
  • 10Harefi A, Mefeed Z, Ghandehari H, Recombinant polymers for cancer gene therapy: A minireview. J Control Release,2005 , 109(1-3) :108 - 119.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部